The addition of anti-PD-L1 therapy after radiation in these studies resulted in a synergistic amplification of tumor killing mediated by TNF-alpha signaling, increased CD8+ T cells, and decreased MDSC within tumors [38]. Here, CD8A is linked to neoplasm.